As of Aug 16
| +0.24 / +5.63%|
The 2 analysts offering 12-month price forecasts for Apollo Endosurgery Inc have a median target of 10.50, with a high estimate of 11.00 and a low estimate of 10.00. The median estimate represents a +133.33% increase from the last price of 4.50.
The current consensus among 2 polled investment analysts is to Buy stock in Apollo Endosurgery Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.